Q1 2023 ImpediMed Ltd Activities Report Call Transcript
Thank you for standing by, and welcome to the ImpediMed Limited quarterly results conference call. (Operator Instructions) I would now like to hand the conference over to Mr. Mike Bassett. Please go ahead.
Thank you, Sari. Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 30 September 2022. I'm Mike Bassett, Senior Vice President of Corporate and Strategic Development. Joining us today on the call is Dave Anderson, Interim CEO; and Tim Cruickshank, our Chief Financial Officer. We'll be referring to 4C and speaking from the quarterly activity report we launched this afternoon, Australia time with the ASX. This presentation is a summary of a more detailed 4C. After our remarks, we'll be taking questions.
Before I turn over to Dave, I'd first like to bring your attention to the record that disclaimer on Page 2 of the presentation deck, the presentation deck
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |